Bioteque Corporation (4107.TWO)
TWD 120.0
(-1.23%)
TWD 120.0
(-1.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 805.34 Million TWD | -4.64% |
| 2022 | 844.54 Million TWD | 5.19% |
| 2021 | 802.86 Million TWD | -5.74% |
| 2020 | 851.75 Million TWD | 4.26% |
| 2019 | 816.95 Million TWD | 18.56% |
| 2018 | 689.04 Million TWD | 14.14% |
| 2017 | 603.67 Million TWD | -3.56% |
| 2016 | 625.97 Million TWD | 13.67% |
| 2015 | 550.7 Million TWD | 15.9% |
| 2014 | 475.16 Million TWD | 23.09% |
| 2013 | 386.04 Million TWD | 31.24% |
| 2012 | 294.14 Million TWD | 22.37% |
| 2011 | 240.37 Million TWD | -22.21% |
| 2010 | 309.01 Million TWD | 10.57% |
| 2009 | 279.46 Million TWD | 44.11% |
| 2008 | 193.92 Million TWD | 34.06% |
| 2007 | 144.65 Million TWD | 11.12% |
| 2006 | 130.17 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 214.45 Million TWD | 6.19% |
| 2024 Q1 | 201.95 Million TWD | -9.76% |
| 2023 Q1 | 179.6 Million TWD | -16.53% |
| 2023 Q2 | 186.66 Million TWD | 3.93% |
| 2023 FY | 805.34 Million TWD | -4.64% |
| 2023 Q4 | 223.8 Million TWD | -0.56% |
| 2023 Q3 | 225.06 Million TWD | 20.57% |
| 2022 Q2 | 215.53 Million TWD | 7.06% |
| 2022 Q4 | 215.18 Million TWD | 1.27% |
| 2022 Q1 | 201.33 Million TWD | -6.62% |
| 2022 FY | 844.54 Million TWD | 5.19% |
| 2022 Q3 | 212.48 Million TWD | -1.41% |
| 2021 Q4 | 215.61 Million TWD | 17.97% |
| 2021 Q1 | 219.73 Million TWD | -9.23% |
| 2021 FY | 802.86 Million TWD | -5.74% |
| 2021 Q2 | 184.74 Million TWD | -15.92% |
| 2021 Q3 | 182.77 Million TWD | -1.07% |
| 2020 FY | 851.75 Million TWD | 4.26% |
| 2020 Q1 | 194 Million TWD | -7.42% |
| 2020 Q4 | 242.09 Million TWD | 10.92% |
| 2020 Q3 | 218.26 Million TWD | 10.57% |
| 2020 Q2 | 197.4 Million TWD | 1.75% |
| 2019 FY | 816.95 Million TWD | 18.56% |
| 2019 Q2 | 214.97 Million TWD | 13.32% |
| 2019 Q1 | 189.7 Million TWD | 2.99% |
| 2019 Q4 | 209.54 Million TWD | 3.36% |
| 2019 Q3 | 202.73 Million TWD | -5.69% |
| 2018 FY | 689.04 Million TWD | 14.14% |
| 2018 Q3 | 170 Million TWD | -3.27% |
| 2018 Q4 | 184.19 Million TWD | 8.34% |
| 2018 Q1 | 159.09 Million TWD | -4.4% |
| 2018 Q2 | 175.75 Million TWD | 10.47% |
| 2017 Q4 | 166.41 Million TWD | 6.1% |
| 2017 Q1 | 133.65 Million TWD | -7.18% |
| 2017 Q3 | 156.84 Million TWD | 6.86% |
| 2017 FY | 603.67 Million TWD | -3.56% |
| 2017 Q2 | 146.77 Million TWD | 9.82% |
| 2016 Q2 | 166.62 Million TWD | 3.04% |
| 2016 Q3 | 153.63 Million TWD | -7.8% |
| 2016 Q4 | 143.99 Million TWD | -6.27% |
| 2016 FY | 625.97 Million TWD | 13.67% |
| 2016 Q1 | 161.71 Million TWD | 11.16% |
| 2015 FY | 550.7 Million TWD | 15.9% |
| 2015 Q1 | 134.55 Million TWD | 3.7% |
| 2015 Q4 | 145.48 Million TWD | 11.72% |
| 2015 Q2 | 140.44 Million TWD | 4.38% |
| 2015 Q3 | 130.21 Million TWD | -7.28% |
| 2014 Q4 | 129.75 Million TWD | 6.43% |
| 2014 FY | 475.16 Million TWD | 23.09% |
| 2014 Q3 | 121.91 Million TWD | 1.82% |
| 2014 Q2 | 119.73 Million TWD | 15.4% |
| 2014 Q1 | 103.75 Million TWD | -0.79% |
| 2013 Q4 | 104.58 Million TWD | 3.67% |
| 2013 FY | 386.04 Million TWD | 31.24% |
| 2013 Q1 | 83.4 Million TWD | 6.39% |
| 2013 Q2 | 97.18 Million TWD | 16.52% |
| 2013 Q3 | 100.88 Million TWD | 3.81% |
| 2012 Q2 | 67.99 Million TWD | -1.92% |
| 2012 Q1 | 69.32 Million TWD | 4.76% |
| 2012 Q3 | 78.43 Million TWD | 15.35% |
| 2012 FY | 294.14 Million TWD | 22.37% |
| 2012 Q4 | 78.38 Million TWD | -0.05% |
| 2011 Q2 | 54.33 Million TWD | -8.14% |
| 2011 Q1 | 59.14 Million TWD | -14.25% |
| 2011 FY | 240.37 Million TWD | -22.21% |
| 2011 Q3 | 60.72 Million TWD | 11.76% |
| 2011 Q4 | 66.17 Million TWD | 8.98% |
| 2010 Q4 | 68.97 Million TWD | -17.23% |
| 2010 Q3 | 83.33 Million TWD | 2.13% |
| 2010 Q2 | 81.59 Million TWD | 8.66% |
| 2010 Q1 | 75.09 Million TWD | 0.0% |
| 2010 FY | 309.01 Million TWD | 10.57% |
| 2009 FY | 279.46 Million TWD | 44.11% |
| 2008 FY | 193.92 Million TWD | 34.06% |
| 2007 FY | 144.65 Million TWD | 11.12% |
| 2006 FY | 130.17 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 975.24 Million TWD | 17.421% |
| Chi Sheng Pharma & Biotech Co., Ltd | 343.1 Million TWD | -134.725% |
| Sunder Biomedical Tech. Co., Ltd. | 77.91 Million TWD | -933.636% |
| BenQ Medical Technology Corporation | 1.34 Billion TWD | 40.074% |
| Pacific Hospital Supply Co., Ltd | 739.74 Million TWD | -8.868% |
| Unicon Optical Co., Ltd. | 98.74 Million TWD | -715.583% |
| Formosa Optical Technology Co.,Ltd. | 2.38 Billion TWD | 66.19% |
| Medeon Biodesign, Inc. | -65.2 Million TWD | 1335.157% |
| Concord Medical Co., Ltd. | 102.14 Million TWD | -688.42% |
| Crystalvue Medical Corporation | 266.74 Million TWD | -201.912% |
| Perfect Medical Industry Co., Ltd. | 200.55 Million TWD | -301.555% |
| ICARES Medicus, Inc. | 482.4 Million TWD | -66.945% |
| Lagis Enterprise Co., Ltd. | 218.88 Million TWD | -267.93% |
| Amed Co., Ltd. | 524.55 Million TWD | -53.529% |